Keyphrases
Spinal muscular Atrophy
100%
Morpholino Oligomers
100%
Transgenic Mice
100%
Intronic Splicing Silencer N1 (ISS-N1)
100%
Exon 7 Inclusion
50%
Antisense Oligonucleotides
37%
Intracerebroventricular Injection
25%
SMN2
25%
At Birth
12%
Patient Fibroblasts
12%
Mouse Model
12%
Systemic Delivery
12%
Clinical Application
12%
High Dose
12%
Splicing Silencer
12%
Dendrimer
12%
Vivo-morpholino
12%
SMN2 Splicing
12%
Tail Necrosis
12%
Neonatal Mice
12%
Systemic Administration
12%
In Vitro Splicing Assay
12%
Peripheral Tissues
12%
Biochemistry, Genetics and Molecular Biology
Exon
100%
Morpholino
100%
Transgenic Mouse
100%
Oligonucleotide
75%
Antisense
75%
SMN2
75%
Lifespan
50%
Mouse Model
25%
Drug Megadose
25%
Intron
25%
Fibroblast
25%
Medicine and Dentistry
Spinal Muscular Atrophy
100%
Transgenic Mouse
100%
Oligomer
100%
Exon
57%
In Vitro
42%
Antisense Oligonucleotide
42%
Intracerebroventricular Drug Administration
28%
Lifespan
28%
Dendrimer
14%
Werdnig Hoffmann Disease
14%
Intron
14%
Tail
14%
Drug Megadose
14%
Ethamoxytriphetol
14%
Necrosis
14%
Systemic Administration
14%
Fibroblast
14%
Neuroscience
Oligomer
100%
Morpholino
100%
Spinal Muscular Atrophy
100%
Exon
50%
In Vitro
37%
Antisense Oligonucleotide
37%
Intron
12%
Necrosis
12%
Fibroblast
12%